| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |